Clinical Trials in Massachusetts

Showing 1081-1100 of 8,511 trials

ShotBlocker During Intramuscular Injection Randomized Control Trial

NCT06624176

The objective of this trial is to evaluate the effect of Bionix ShotBlocker on pain of injection of the first Hepatitis B vaccine in healthy newborns. ShotBlocker is a pain reducing tool used in babies, children, and adults for injections. Swaddling during the injection and administration of oral sucrose prior to the injection are established standards of care for painful procedures in neonates. The investigators hypothesize that the use of ShotBlocker in addition to swaddling and oral sucrose administration will lessen the pain response.

Neonatal Pain

Lauren Fortier200 participantsStarted Jan 2024

Worcester, Massachusetts, United States

Active Not RecruitingPhase 318 miles

A Study of Brepocitinib in Adults With Active, Non-Infectious, Non-Anterior Uveitis

NCT06431373

The purpose of this study is to determine the safety and efficacy of brepocitinib in participants with active, non-anterior (intermediate, posterior, or pan) non-infectious uveitis (NIU).

Uveitis, PosteriorUveitis, IntermediateUveitis

Priovant Therapeutics, Inc.371 participantsStarted Sep 2024

Phoenix, Arizona, United States • Phoenix, Arizona, United States • Bakersfield, California, United States +104 more locations

ShotBlocker During Intramuscular Injection Randomized Control Trial

A Study of Brepocitinib in Adults With Active, Non-Infectious, Non-Anterior Uveitis

Find Trials by Condition in Massachusetts

PoNS® Therapy for Gait and Balance Deficits in Chronic Stroke Survivors: A Single-Arm Study

ASSESS ALL ALS Study

Radiation- and Alkylator-free Bone Marrow Transplantation Regimen for Patients With Dyskeratosis Congenita

A Study of the Safety and Tolerability of GTX-102 in Children With Angelman Syndrome

Study of Regorafenib in Patients With Advanced Myeloid Malignancies

A Phase 2 Study of Durvalumab in Combination With Tremelimumab in Malignant Pleural Mesothelioma

Biomarkers of Response to Ipilimumab and Nivolumab in First-line NSCLC

Pharmacist Intervention to Reduce Post-Hospitalization Utilization

A Study to Assess Adjuvant Immunotherapy With Nivolumab Plus Relatlimab Versus Nivolumab Alone After Complete Resection of Stage III-IV Melanoma

Use of the Impella BTR™ in Patients With Heart Failure: An Early Feasibility Study

Study of Bitopertin to Evaluate the Safety, Tolerability, Efficacy, and PPIX Concentrations in Participants With EPP

A Phase 1/2 Study to Investigate CRB-701 in Solid Tumors

A Study to Evaluate the Efficacy and Safety of Golcadomide in Combination With Rituximab in Participants With Newly Diagnosed Advanced Stage Follicular Lymphoma

A Trial to Learn if the Combination of Fianlimab, Cemiplimab, and Chemotherapy is Safe and Works Better Than the Combination of Cemiplimab and Chemotherapy in Adult Patients With Non-Small Cell Lung Cancer That Can be Treated With Surgery

A Study Assessing Adverse Event and How Oral ABBV-453 Moves Through the Body in Adult Participants With Relapsed or Refractory (R/R) Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)

A Phase 1 Study of UB-VV111 With and Without Rapamycin in Relapsed/Refractory CD19+ B-cell Malignancies

A Study to See if an Investigational Medicine Called VS-01 Can Help and How Safe it is in the Treatment of Patients With Overt Hepatic Encephalopathy

A Study of Relatlimab in Combination With Nivolumab in Participants With Advanced Liver Cancer Who Have Never Been Treated With Immuno-oncology Therapy After Prior Treatment With Tyrosine Kinase Inhibitors